首页> 外文期刊>Frontiers in Cardiovascular Medicine >p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway
【24h】

p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway

机译:P90RSK-MAGI1模块通过MAGI1和HIPPO路径的翻译修改控制内皮渗透性

获取原文
获取外文期刊封面目录资料

摘要

Previously, we reported that post-translational modifications (PTMs) of MAGI1, including S741 phosphorylation and K931 de-SUMOylation, both of which are regulated by p90RSK activation, lead to endothelial cell (EC) activation. However, roles for p90RSK and MAGI1-PTMs in regulating EC permeability remain unclear despite MAGI1 being a junctional molecule. Here, we show that thrombin (Thb)-induced EC permeability, detected by the electric cell-substrate impedance sensing (ECIS) based system, was decreased by overexpression of dominant negative p90RSK or a MAGI1-S741A phosphorylation mutant, but was accelerated by overexpression of p90RSK, siRNA-mediated knockdown of magi1 , or the MAGI1-K931R SUMOylation mutant. MAGI1 depletion also increased the mRNA and protein expression of the large tumor suppressor kinases 1 and 2 (LATS1/2), which inhibited YAP/TAZ activity and increased EC permeability. Because the endothelial barrier is a critical mediator of tumor hypoxia, we also evaluated the role of p90RSK activation in tumor vessel leakiness by using a relatively low dose of the p90RSK specific inhibitor, FMK-MEA. FMK-MEA significantly inhibited tumor vessel leakiness at a dose that does not affect morphology and growth of tumor vessels in vivo . These results provide novel insights into crucial roles for p90RSK-mediated MAGI1 PTMs and the Hippo pathway in EC permeability, as well as p90RSK activation in tumor vessel leakiness.
机译:以前,我们报道了MAGI1的翻译后修饰(PTM),包括S741磷酸化和K931脱象,这两者都受到P90RSK活化的调节,导致内皮细胞(EC)活化。然而,尽管Magi1是结分子,P90RSK和MAGI1-PTMS在调节EC渗透率方面的作用仍不清楚。这里,我们表明,通过基于电池 - 基质阻抗检测(ECIS)的系统检测的凝血酶(THB)引起的EC渗透率通过显性负P90RSK或MAGI1-S741A磷酸化突变体的过表达,但通过过表达加速P90RSK,siRNA介导的MAGI1的敲低,或MAGI1-K931R Sumoylation突变体。 MAGI1耗竭也增加了大肿瘤抑制作用激酶1和2(LATS1 / 2)的mRNA和蛋白表达,其抑制了YAP / TAZ活性并增加了EC渗透性。因为内皮屏障是肿瘤缺氧的关键介质,我们还通过使用相对低剂量的P90RSK特异性抑制剂,FMK-MEA评估P90RSK活化在肿瘤血管泄漏中的作用。 FMK-MEA在不影响体内肿瘤血管的形态和生长的剂量下显着抑制肿瘤血管泄漏。这些结果为P90RSK介导的MAGI1 PTM和eC渗透率中的河马通路提供了新的洞察力,以及肿瘤血管泄漏中的P90RSK活化。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号